Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wise Owl Biologics is a regenerative medicine company specializing in the development and distribution of amniotic-derived biologic products. The company's portfolio focuses on utilizing the natural healing properties of human birth tissues to treat orthopedic conditions, chronic wounds, and aesthetic concerns. Their flagship products are designed to provide a scaffold for tissue repair and reduce inflammation without the need for invasive surgery. Wise Owl Biologics serves clinicians in the fields of sports medicine, podiatry, and pain management. The company emphasizes safety and quality in its processing of allografts to ensure optimal patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wise Owl Biologics.